Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,964Revenue (TTM) $M366Net Margin (%)-1.3Altman Z-Score9.8
Enterprise Value $M1,919EPS (TTM) $-0.1Operating Margin %-1.2Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-1.7Higher ROA y-yY
Price/Book9.610-y EBITDA Growth Rate %--Quick Ratio2.0Cash flow > EarningsY
Price/Sales5.35-y EBITDA Growth Rate %19.4Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %72.8ROA % (ttm)-1.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-2.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M65.7ROIC % (ttm)-3.1Gross Margin Increase y-yY

Gurus Latest Trades with NXTM

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NXTM is held by these investors:



NXTM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Swan Winifred LSVP and General Counsel 2017-04-20Sell3,500$27.289.57view
TOWSE MATTHEW WSVP and Chief Financial Office 2017-04-20Sell4,300$27.289.57view
Burbank Jeffrey HCEO 2017-04-20Sell3,000$27.289.57view
Burbank Jeffrey HCEO 2017-04-19Sell3,000$26.6512.16view
Turk Joseph E JrPresident 2017-04-13Sell1,000$26.114.52view
Brown Robert S.President, NxStage Kidney Care 2017-04-03Sell14,397$26.612.37view
Burbank Jeffrey HCEO 2017-03-22Sell3,000$27.429.01view
Burbank Jeffrey HCEO 2017-03-21Sell3,000$27.727.83view
TOWSE MATTHEW WSVP and Chief Financial Office 2017-03-20Sell4,300$27.668.06view
Swan Winifred LSVP and General Counsel 2017-03-20Sell15,723$27.668.06view

Quarterly/Annual Reports about NXTM:

News about NXTM:

Articles On GuruFocus.com
NxStage® to Report First Quarter 2017 Financial Results Apr 06 2017 
Weekly 3-Year Low Highlights: MFLX, NXTM, CVRR, CMLP Nov 10 2013 
NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Mar 18 2011 
NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Mar 18 2011 
NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Feb 18 2011 
NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Feb 18 2011 
NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Jan 21 2011 
NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Jan 20 2011 
NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 13,710 Shares Dec 17 2010 
NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 12,000 Shares Dec 16 2010 

More From Other Websites
NxStage Medical, Inc. – Value Analysis (NASDAQ:NXTM) : April 24, 2017 Apr 24 2017
NxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : April 21,... Apr 21 2017
NxStage® to Report First Quarter 2017 Financial Results Apr 06 2017
NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : March 21,... Mar 21 2017
NxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : March 10,... Mar 10 2017
New Data Shows Significant Potential Cost Savings with On-Site Hemodialysis in Skilled Nursing... Mar 09 2017
NxStage Medical: NxGen Hemodialysis System Now CE Marked Mar 03 2017
NxStage Medical Announces CE Mark for its NxGen Hemodialysis System Mar 02 2017
NxStage Medical, Inc. :NXTM-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017 Mar 02 2017
Edited Transcript of NXTM earnings conference call or presentation 28-Feb-17 2:00pm GMT Feb 28 2017
2017 Should Bring NxStage Medical a Profit Feb 28 2017
NxStage reports 4Q loss Feb 28 2017
NxStage Reports Fourth Quarter and Full-Year 2016 Financial Results Feb 28 2017
NxStage Announces First Quarter 2017 Investor Conference Schedule Feb 16 2017
NxStage Announces Appointment of Chief Medical Officer Feb 03 2017
NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : January 25,... Jan 25 2017
ETFs with exposure to NxStage Medical, Inc. : January 19, 2017 Jan 19 2017
NxStage® to Report Fourth Quarter and Full Year 2016 Financial Results Jan 16 2017
Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay Jan 04 2017
Illumina Fettered With Losses: Can It Bounce Back in 2017? Jan 03 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)